Brequinar is a potent quinoline carboxylic acid derivative that functions as a selective inhibitor of dihydroorotate dehydrogenase, an enzyme critical for de novo pyrimidine biosynthesis. By disrupting… Read more
Brequinar is a potent quinoline carboxylic acid derivative that functions as a selective inhibitor of dihydroorotate dehydrogenase, an enzyme critical for de novo pyrimidine biosynthesis. By disrupting DNA synthesis, this compound has been investigated for its therapeutic potential in treating various malignant lymphomas and leukemias. Pharmaceutical laboratories utilize Brequinar reference standards, along with its specific impurities, metabolites, and stable isotope-labelled compounds, to support rigorous analytical testing and quality control protocols. These high-quality materials are essential for impurity profiling, method development, and the validation of quantitative assays in complex biological and pharmaceutical matrices. Whether performing stability studies or ensuring the accuracy of chromatographic analyses, these research materials provide the necessary controls to monitor drug degradation and metabolic pathways effectively during pharmaceutical development.